- •Thyroid nodules are a typical incidental finding.
- •Thyroid nodules should be evaluated through ultrasound for metastatic features.
- •Benign thyroid nodules require routine monitoring for noncancer complications such as dysphagia, dysphonia, or shortness of breath.
- •High-risk thyroid nodules require ultrasound-guided fine-needle aspiration biopsy.
An increase in the identification of thyroid nodules (TNs) leads to a subsequent increase in benign nodules being misdiagnosed as malignant. The American Thyroid Association has recognized that most TNs are benign and has developed clinical guidelines to guide clinical decision making for the reduction of excessive thyroidectomy. Evaluation and treatment of TNs is recommended for all nodules identified through palpation and incidentally through advanced imaging. The goal of evaluation is to initiate accurate monitoring and management recommendations based on malignancy risk determined by patient history, physical examination, ultrasound imaging, and fine-needle aspiration biopsy when indicated.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The Journal for Nurse Practitioners
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Ultrasound of thyroid nodules and the thyroid imaging reporting and data system.Neuroimaging Clin N Am. 2021; 31: 285-300https://doi.org/10.1016/j.nic.2021.04.001
- Thyroid nodules: advances in evaluation and management.Am Fam Physician. 2020; 102: 298-304
- Diagnosis and evaluation of thyroid nodules—the clinician's perspective.Radiol Clin North Am. 2020; 58: 1009-1018https://doi.org/10.1016/j.rcl.2020.07.007
- Update on fundamental mechanisms of thyroid cancer.Front Endocrinol (Lausanne). 2020; 11: 102https://doi.org/10.3389/fendo.2020.00102
- Is thyroid nodule location associated with malignancy risk?.Ultrasonography. 2019; 38: 231-235https://doi.org/10.14366/usg.18050
- Review of factors contributing to nodular goiter and thyroid carcinoma.Med Princ Pract. 2020; 29: 1-5https://doi.org/10.1159/000503575
- Bethesda thyroid categories and family history of thyroid disease.Clin Endocrinol. 2017; 88: 468-472https://doi.org/10.1111/cen.13538
- 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed?.Cancer. 2017; 123: 372-381https://doi.org/10.1002/cncr.30360
- 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid. 2016; 26: 1-133https://doi.org/10.1089/thy.2015.0020
- Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment.BMJ. 2020; 368: l6670https://doi.org/10.1136/bmj.l6670
- Predictive quantitative sonographic features on classification of hot and cold thyroid nodules.Eur J Radiol. 2018; 101 (doi:S0720-048X(18)30048-2): 170-177
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules—2016 update.Endocr Pract. 2016; 22: 622-639https://doi.org/10.4158/EP161208.GL
- Progress and challenges in thyroid cancer management.Endocr Pract. 2021; 27: 1260-1263https://doi.org/10.1016/j.eprac.2021.09.006
- Ultrasound imaging classifications of thyroid nodules for malignancy risk stratification and clinical management: state of the art.Gland Surg. 2019; 8: S233-S244https://doi.org/10.21037/gs.2019.07.01
- Thyroid nodules: diagnosis and management.Med J Aust. 2018; 209: 92-98https://doi.org/10.5694/mja17.01204
- Incidence and malignancy rates classified by the Bethesda system for reporting thyroid cytopathology (TBSRTC)—an 8-year tertiary center experience in Thailand.J Clin Transl Endocrinol. 2019; 16100175https://doi.org/10.1016/j.jcte.2018.12.004
- Predictive value of malignancy of thyroid nodule ultrasound classification systems: a prospective study.J Clin Endocrinol Metab. 2018; 103: 1359-1368https://doi.org/10.1210/jc.2017-01708
- Diagnostic value of AngioPLUS microvascular imaging in thyroid nodule diagnosis using quantitative and qualitative vascularity grading.Biomedicines. 2022; 10: 1554https://doi.org/10.3390/biomedicines10071554
- Intranodular vascularity may be useful in predicting malignancy in thyroid nodules with the intermediate suspicion pattern of the 2015 American Thyroid Association guidelines.Ultrasound Med Biol. 2020; 46: 1373-1379https://doi.org/10.1016/j.ultrasmedbio.2020.02.016
- Thyroid nodules located in the lower pole have a higher risk of malignancy than located in the isthmus: a single-center experience.Int J Endocrinol. 2021; 20219940995https://doi.org/10.1155/2021/9940995
- Investigating the effect of thyroid nodule location on the risk of thyroid cancer.Thyroid. 2020; 30: 401-407https://doi.org/10.1089/thy.2019.0478
Cesalie D. Wallace, DNP, FNP-BC, who can be contacted at [email protected], and Margaret Love, DNP, FNP-BC, are nurse practitioners at the University of Arkansas Medical Center, Little Rock.
Published online: February 08, 2023
In compliance with standard ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.
© 2023 Elsevier Inc. All rights reserved.